Search
Andrew "Drew" Matz, MD, MPH serves as an attending physician on the GWUH Inpatient Behavioral Health Unit. He holds the academic rank of assistant professor of psychiatry and behavioral sciences at the GW School of Medicine & Health Sciences. Prior to his work at GW, Dr. Matz served as an…
Complete the following form to edit or remove existing provider profiles or to request an update to the website. Once received, changes will be reflected within 3-5 business days.
Elizabeth L. Cobbs MD is an internist, geriatrician and palliative medicine doctor with The GW Medical Faculty Associates and a professor of medicine with The George Washington University School of Medicine and Health Sciences. She completed her undergraduate degree at Vassar College and graduated…
People who keep weight off tend to have several habits in common. The following strategies can help you achieve long-term weight loss.
Exercise every day
People in the National Weight Control Registry, a group of more than 10,000 members, have lost an average of 60 pounds and kept their weight…
Mamoun Younes, MD, FCAP, AGAF is a nationally recognized gastrointestinal and liver pathologist. He is currently Vice Chair in the Department of Pathology, and Director of Surgical Pathology at George Washington University Hospital.
Shabnam Samankan MD, is an assistant professor of gynecologic, breast and ENT pathology in the Department of Pathology at George Washington University (GW) and the Division Chief of Head & Neck and Endocrine Pathology. Prior to joining GW, Dr. Samankan completed a subspecialty fellowship…
Irena Manukyan MD, PhD is an assistant professor and chief of molecular genetic oncology service in the Department of Pathology at George Washington University (GW). Her expertise is in areas of genomic and molecular diagnostic pathology and cytopathology. Prior to joining GW, she completed a…
Rebecca Yee, Ph.D, D(ABMM) is the Chief of Microbiology and Assistant Professor in the Department of Pathology at George Washington University.
Primary objective: The primary objective of the study is to compare disease-free survival (DFS) of patients with high-risk cutaneous squamous cell carcinoma (CSCC) treated with adjuvant cemiplimab, versus those treated with placebo, after surgery and radiation therapy (RT).